NRx Pharmaceuticals, Inc. (NRXP) financial statements and ratios from SEC XBRL: revenue $1.23M (TTM), net margin -2336.5%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $1.23M |
| Net Margin | -2336.5% |
| Price / Sales | 43.93 |
| FCF Yield | -9.2% |
| Altman Z-Score | -36.60 (distress) |
| Sector P/E (Healthcare) | 21.7 |
NRXP overview · NRXP earnings · NRXP KPIs · NRXP investor relations · NRXP ownership · NRXP peers · NRXP filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.